NCT01973439View on ClinicalTrials.gov

PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2009

Conditions
HIV Infection
Interventions
OTHER

Intervention 1: PK assessment while on Twice Daily Abacavir

Week 0

OTHER

Intervention 2: PK assessment while on Once Daily Abacavir

Week 4

Trial Locations (10)

35128

Clinica Pediatrica, Università di Padova, Padua

Unknown

Hôpital Port Royal, Paris

Hôpital Robert Debré, Paris

Immundefekt-Ambulanz, Dr. von Haunersches Kinderspital, Munich

Hospital Universitario, Getafe

Hospital 12 de Octubre, Madrid

Hospital Gregorio Maranon, Madrid

Birmingham Heartlands Hospital, Birmingham

Evelina Children's Hospital, London

St. Mary's Hospital, London

All Listed Sponsors
lead

PENTA Foundation

NETWORK

NCT01973439 - PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months | Biotech Hunter | Biotech Hunter